Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cultured conjunctival epithelial cell sheet transplantation for corneal epithelial stem cell deficiency
jRCTb030250605Recruiting
- Start
- Dec 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in limbal stem cell deficiency (LSCD). Primary endpoint: Safety at 3 months postoperatively. Started Dec 2025; status: recruiting.
02
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on jRCTb030250605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb030250605.